-
Who will achieve pCR? An interpretable AI model with contrast-enhanced ultrasound to predict treatment response
An interpretable CatBoost model combining routine clinical data and contrast-enhanced ultrasound predicts pathological complete response in breast cancer before
-
Exploratory immunomonitoring during radiochemotherapy in HNSCC and machine-learning reveal immune parameters associat…
A prospective study of 70 HNSCC patients found that a 29-parameter blood immune signature, identified by machine learning, predicts disease-free survival after
-
A Habitat Imaging-Based Radiomics and Deep Learning Fusion for Preoperative Prediction of Lymphovascular Invasion in …
A multicenter study demonstrates that fusing habitat-based radiomics with deep learning on routine ultrasound can accurately predict lymphovascular invasion in
-
Artificial Intelligence-enhanced cardiac MRI reporting: expert validation and patient-centered outcomes.
A prospective study demonstrates that ChatGPT-4o can simplify cardiac MRI reports without losing accuracy, significantly improving patient understanding and satisfaction. The im
-
Kidney stones composition prediction using artificial intelligence (KiSCAI) study.
Predicting the composition of kidney stones using artificial intelligence could transform clinical management. A recent study shows that machine learning models, especially when
-
Artificial intelligence in Latin American hepatology: current evidence, implementation barriers, and strategic priori…
Artificial intelligence in Latin American hepatology: current evidence, implementation barriers, and strategic priori…
-
Emerging frontiers and challenges of artificial intelligence in PSMA-PET imaging: pioneering a new chapter in prostat…
PSMA-PET has become the standard in prostate cancer management, but subjective interpretation and heterogeneous expression limit its potential. Artificial intelligence (AI) is t
-
A Case of Concurrent Liver Metastases from Colorectal and Breast Cancer Diagnosed Using Percutaneous Tumor Biopsy.
Un caso de metástasis hepáticas simultáneas de cáncer de mama y colorrectal, diagnosticadas mediante biopsia percutánea, subraya que en pacientes con múltiples neoplasias primar
-
Efficacy, safety, and biomarker analysis of neoadjuvant camrelizumab plus apatinib as a chemotherapy-free strategy fo…
Un ensayo fase II evalúa la combinación de camrelizumab y apatinib como estrategia neoadyuvante sin quimioterapia en cáncer de mama triple negativo temprano, mostrando una tasa
-
Prognostic Models and Predictors of Recurrence in Resectable Colorectal Liver Metastases: A Systematic Review and Met…
Un metaanálisis de 293 estudios identifica la positividad del ADN tumoral circulante (ctDNA) postoperatorio como el predictor más fuerte de recurrencia en metástasis hepáticas r